scholarly article | Q13442814 |
P356 | DOI | 10.1515/BC.2002.016 |
P698 | PubMed publication ID | 11928810 |
P50 | author | Christophe Stove | Q40479091 |
Marc Bracke | Q55232071 | ||
P2093 | author name string | Marc Goethals | |
Joël Vandekerckhove | |||
Erik Bruyneel | |||
Marc Mareel | |||
Filip Ryniers | |||
Liesbeth Brackenier | |||
Veerle Noë | |||
P2860 | cites work | Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion | Q28142815 |
Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence | Q28244489 | ||
The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis | Q34165118 | ||
The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow | Q34223998 | ||
Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin | Q34290465 | ||
Role of myofibroblasts at the invasion front | Q34584808 | ||
Soluble E-cadherin fragments increased in circulation of cancer patients | Q35978360 | ||
Characterization of soluble E-cadherin as a disease marker in gastric cancer patients | Q36115556 | ||
Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion | Q36115941 | ||
Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence | Q36135912 | ||
Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene | Q36232389 | ||
An in vivo structure-function study of armadillo, the beta-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling | Q36237334 | ||
In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death | Q36382475 | ||
Soluble forms of the adhesion molecule E-cadherin in urine | Q39642989 | ||
Oncogenic activation of tyrosine kinases | Q40757534 | ||
Cleavage and shedding of E-cadherin after induction of apoptosis | Q40842886 | ||
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors | Q40949632 | ||
Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties | Q41126999 | ||
TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment | Q41233767 | ||
Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA). | Q41260093 | ||
Cadherin-dependent cell aggregation is affected by decapeptide derived from rat extracellular super-oxide dismutase. | Q41349178 | ||
The urokinase-type plasminogen activator system in cancer metastasis: A review | Q41522331 | ||
E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion | Q41640504 | ||
ECM and cell surface proteolysis: regulating cellular ecology | Q41656253 | ||
Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice | Q45754755 | ||
Purification and characterization of NCAD90, a soluble endogenous form of N-cadherin, which is generated by proteolysis during retinal development and retains adhesive and neurite-promoting function. | Q52223290 | ||
P433 | issue | 1 | |
P304 | page(s) | 159-165 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Biological Chemistry | Q4914948 |
P1476 | title | Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion | |
P478 | volume | 383 |
Q33878896 | ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. |
Q80503595 | ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis |
Q44366812 | Altered gene expression in mouse livers after dichloroacetic acid exposure |
Q36615956 | Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer. |
Q38679713 | Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer. |
Q24629108 | Cancer Cells Cut Homophilic Cell Adhesion Molecules and Run |
Q42734789 | Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. |
Q37428089 | Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis |
Q101124627 | Curcumin Inhibits the Migration and Invasion of Non-Small-Cell Lung Cancer Cells Through Radiation-Induced Suppression of Epithelial-Mesenchymal Transition and Soluble E-Cadherin Expression |
Q31134141 | DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells |
Q40796445 | Differential downregulation of e-cadherin and desmoglein by epidermal growth factor. |
Q34471105 | Distinct roles for cysteine cathepsin genes in multistage tumorigenesis |
Q26865483 | E-cadherin's dark side: possible role in tumor progression |
Q39453489 | EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells. |
Q40511545 | Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3. |
Q35884866 | Epithelial-mesenchymal transition in oral squamous cell carcinoma |
Q41430438 | Evidence for cadherin-11 cleavage in the synovium and partial characterization of its mechanism |
Q39104038 | Exploiting the Gastric Epithelial Barrier: Helicobacter pylori's Attack on Tight and Adherens Junctions |
Q35017040 | Fate of E-cadherin in early RPE cultures: transient accumulation of truncated peptides at nonjunctional sites |
Q30319058 | Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10. |
Q85166357 | Increased Levels of Soluble Vascular Endothelial Cadherin are Associated with Poor Outcome in Severe Sepsis |
Q28292665 | Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin |
Q40036786 | Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner |
Q33906860 | MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis |
Q37565430 | MT2-MMP induces proteolysis and leads to EMT in carcinomas |
Q48312486 | Mangiferin blocks proliferation and induces apoptosis of breast cancer cells via suppression of the mevalonate pathway and by proteasome inhibition |
Q90665051 | MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread |
Q40074094 | Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma |
Q40715721 | Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes |
Q34584808 | Role of myofibroblasts at the invasion front |
Q35170428 | Role of tissue stroma in cancer cell invasion |
Q34279705 | Soluble E-cadherin: more than a symptom of disease. |
Q40222376 | Soluble N-cadherin fragment promotes angiogenesis |
Q36977717 | Soluble cadherins as cancer biomarkers |
Q36326605 | Targeting Cathepsin B for Cancer Therapies |
Q30362587 | Use of silicon chip technology to detect protein-based tumor markers in bladder cancer |
Search more.